Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087

CODEN : IJPPTK

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...

Article type

Original Article


Article page

180-186


Authors Details

Rajesh Pandey*, Ashok Mesharm


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 259

PDF Downloaded: 204


Mortality analysis in cases of COVID-19 during the second wave at a tertiary care center in western India


Original Article

Author Details : Rajesh Pandey*, Ashok Mesharm

Volume : 9, Issue : 3, Year : 2022

Article Page : 180-186

https://doi.org/10.18231/j.ijpp.2022.032



Suggest article by email

Get Permission

Abstract

India witnessed a devastating second surge of COVID-19 cases from March 2021. Evidence strongly advocates its association with the patients’ age, gender, pre-existing comorbidity, vaccination status, and Remdesivir administration during the treatment of the disease. The objective of this study is to evaluate the significant relation of these five factors to in-hospital COVID-19 mortalities. We conducted a retrospective, cross-sectional, and observational cohort study between Jan 01 and May 30, 2021 in a tertiary care center in India. The outcome of interest is to identify the effect of vaccination, co-morbidities, and Remdesivir administration on COVID-19 mortality using SPSS software version 25.0 (IBM Corp., Armonk, NY, USA). The mortality rate was found to be 6.8 % (N=117) during hospitalization. The mean age of patients who died due to COVID-19 was 70.41 ± 15.04 years and the median was 68.34 (IQR: 59.61-83.38) years. About 89% of the population was over 55 years of age. The mortality rate was found to be higher in males (N=77; 65.8%). Out of 117 deaths, 95 patients (81.2%) were unvaccinated, whereas only 15.4% (N=18) and 3.4% (N=4) have taken a single and double dose respectively. Approximately, 3 quarter of patients had 1 or more comorbidity. Remdesivir administration is associated with the survival of 84.0% in moderate to severe COVID-19 infected patients. Results of our study coincide with the outcomes of studies done in the past concluding that age, gender, pre-existing comorbidities, vaccination status, and Remdesivir administration, these five factors are associated with COVID-19 mortalities.


Keywords: COVID­19, Hospitalization, Mortality, Remdesivir, Second wave, SARS­CoV­2


How to cite : Pandey R, Mesharm A, Mortality analysis in cases of COVID-19 during the second wave at a tertiary care center in western India. Indian J Pharm Pharmacol 2022;9(3):180-186

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.